Joe Diruzzo of Fuerst Ittleman petitions United States Supreme Court for Writ of Certiorari [PDF] On January 10, 2010, Joseph A. DiRuzzo, III, Esq., CPA, an associate at Fuerst Ittleman filed […]
The U.S. District Court for the Eastern District of Pennsylvania has held that Federal Rule of Evidence 407, which prohibits evidence of measures taken after an injury or harm, which […]
Following its audits of the Internal Revenue Service’s (IRS) Large and Mid-Size Business (LMSB) and Small Business/Self Employed(SB/SE) Divisions, the Treasury Inspector General for Tax Administration (TIGTA) recently released its findings regarding the “the effectiveness of controls and procedures” utilized by the two Divisions.
As the new year begins, federal prosecutors continue their efforts at cracking down on online poker in the US. The latest has not focused on the numerous online poker sites or the 2.5 million Americans that regularly play.
The Eleventh Circuit Court of Appeals in Atlanta on December 28, 2010 rendered a decision in an unpublished opinion finding that a failure to raise a forum selection clause in […]
Aldagen, Inc. announced yesterday that the FDA has cleared its investigational new drug (IND) application, allowing the biopharmaceutical company to proceed with phase II clinical trials. The focus of the clinical trials will be on the development of a stem cell therapy for treatment of stroke patients.
Florida has become infamous for clinics, known as “Pill Mills,” that dole out tremendous amounts of pain medications. And within the state of Florida, no county has seen more Pill […]
In what may be a sign that the FDA is loosening its grip on human embryonic stem cell (hESC) research, Advanced Cell Technology (ACT) announced that it has been cleared by the FDA to begin a new round of human clinical trials.
Good news for U.S. companies, venture capitalists are optimistic about 2011. A national survey (found here) released by the National Venture Capital Association and Dow Jones VentureSource involving more than […]
A new British anti-bribery law taking effect in April, in certain ways more stringent than the Foreign Corrupt Practices Act (“FCPA”) in the United States, is worrying American drug companies enough begin strengthening existing […]
